Ben: Yeah, for sure. I think you have hit on a point actually that might be good for some clarification. Obviously with myself being on the forums, I see quite a lot of things being written down. Can you clarify your stance on publications for people, because I think sometimes it’s being confused somewhat about how publications, and OMF (Open Medicine Foundation), and the genome center work and what your aims are? Can you briefly clarify your stance on the publication process? What is perhaps wrong with it in general?
Ron: Well, we feel that the community needs the data that you collect as soon as possible, but what they also need is making sure that the data is in fact valid.
Ben: yes.
Ron: So, that is another process. You may have collected it, but if you are not sure that it is right and it is not necessarily because someone did something wrong. It has to do with uncovering something in the process that’s made you suspicious. Then you have to do a lot more work to make sure, that in fact, it is valid data. You do not want to release the data until you know that it is true.
Ben: yes.
Ron: That’s frustrating. Then you have the problem with publications. I think that what we see in the review process of papers and grants is very much like the experience with trolls on the internet. I basically think of them as a bunch of trolls, reviewers. There is something psychological. I have talked to Janet about this. When you are allowed to criticize and you are given the power to criticize all you want and nobody knows who you are, which you see on the internet all the time, people sometimes get incredibly nasty. Unnecessarily nasty. I think that is a problem with society in general.
Ben: It is that anonymity factor.
Ron: Yes, and I think it’s hiding behind, and you understand, you don’t want those individuals doing the review to be attacked. That’s why you keep them secretive. It seems to me that somebody else needs to overlook that and make sure that they are not being unnecessarily nasty. In fact to check that the criticisms are in fact valid.
Ben: yes.
Ron: That’s the secondary level which is what the editor should do and the grant manager should be doing. And they do not do that. I think it including an extremely negative personal attack should be thrown out. That will stop it.
Ben: Mhmm.
Ron: People will know that if I put something super harsh but that is really a personal attack then I am wasting my time.
Ben: yeah.
Ron: Anyway, I think we need some fixes on that. I am really worried about the young people in science. I have had enough experience. I’d say “Oh yeah, there is another negative, There’s another troll!” and kind of dismiss it. But the young people, sometimes you know, they do not know how to deal with that and they take it very personal that they are not a good scientist. That’s not good for anybody.
Ben: Mhmm.
Ron: There are a lot of very talented people there, it’s incredible. So this is a totally secondary thing, but it’s that people might like to know that the frustrations of actually doing the research. You have the frustrations of the actual research, and then the frustrations of the people looking over your shoulder.
Ben: Yeah, I understand. I mean what one point that comes up, that is kind of tied in with that, but secondary, is that some people have maybe, perhaps, been confused over the fact that they didn’t want to publish. That isn’t true is it? It is not about not wanting to publish. I mean you can tell me about that.
Ron: I certainly want to publish. It’s actually a little, you know, you are going to get heavy criticism so there is a little bit of intimidation there. Someone is going to find something wrong and then you are going to start arguing.
Ben: Mhmm.
Ron: But no, why would you do the research if you didn’t publish. The concern really is the fact is it really correct. And there is some stuff on our patient data that I am suspicious of. I don’t know what is wrong (with the patient data). I am just looking at the data. Is this really valid? People ask why we are not putting it up. It’s the gene expression stuff and I look at it compared to our trauma and it just doesn’t seem right. I think what we are going to have to do is go back. The problem is with the severely ill we really can’t sample those patients again. I am trying to come up with what can we do to see if in fact it is valid. We will have to do an extra experiment and I think it’s the processing that we chose to use to try to get better data. I think it may not have done it. I think it means we have to develop a different process to validate that data.